Human medicines European public assessment report (EPAR): Xeristar, duloxetine, Anxiety Disorders,Depressive Disorder, Major,Diabetic Neuropathies, Date of authorisation: 17/12/2004, Revision: 28, Status: Authorised
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.